| 2026-08-14 | Press release | Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update |
| 2026-08-13 | Presentation | Corporate Presentation August 2026 |
| 2026-07-27 | Press release | Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026 |
| 2026-07-25 | Presentation | Corporate Presentation |
| 2026-06-15 | Press release | Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update |
| 2026-05-12 | Press release | Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference |
| 2026-05-07 | Press release | Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
| 2026-05-01 | Presentation | Corporate Presentation |
| 2026-04-06 | Press release | Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference |
| 2026-03-30 | Presentation | Corporate Presentation |
| 2026-03-30 | Press release | Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
| 2026-03-16 | Press release | Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026 |
| 2026-02-10 | Presentation | Guggenheim Emerging Outlook: Biotech Summit 2026 Presentation |
| 2026-02-10 | Presentation | Corporate Presentation |
| 2026-02-04 | Press release | Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 |
| 2026-01-05 | Presentation | Neumora NMRA-511 Update Conference Call Presentation |
| 2026-01-05 | Press release | Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones |
| 2026-01-05 | Press release | Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agita |
| 2025-11-11 | Presentation | Corporate Presentation |
| 2025-11-03 | Press release | Neumora Therapeutics to Participate in Upcoming Conferences in November |
| 2025-10-27 | Presentation | Neumora Therapeutics R&D Day Presentation |
| 2025-10-27 | Press release | Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898 |
| 2025-10-27 | Press release | Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity |
| 2025-10-01 | Press release | Neumora Therapeutics to Host Virtual R&D Day on October 27 |
| 2025-09-02 | Press release | Neumora Therapeutics to Participate in Upcoming Conferences in September |
| 2025-08-06 | Presentation | Corporate Presentation |
| 2025-07-09 | Presentation | Corporate Presentation |
| 2025-07-09 | Press release | Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861 |
| 2025-05-01 | Presentation | Corporate Presentation |
| 2025-03-03 | Press release | Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update |
| 2025-01-02 | Press release | Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder |
| 2024-11-06 | Press release | Neumora Therapeutics to Participate in Upcoming Conferences in November |
| 2024-08-14 | Press release | Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric D |
| 2024-06-20 | Press release | Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation |
| 2024-05-14 | Press release | Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression |
| 2024-05-06 | Press release | Neumora Therapeutics to Participate in Upcoming Conferences in May |
| 2024-04-15 | Press release | Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study |
| 2024-03-13 | Press release | Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days |
| 2024-03-07 | Press release | Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update |
| 2024-01-15 | Presentation | 42nd Annual J.P. Morgan Healthcare Conference Presentation |